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Background
25-hydroxyvitamin D (25[OH]D) plays an essential role in
the homeostasis of calcium and bone metabolism, but it is
acknowledged as an immunomodulator as well. Several
studies have described a high prevalence of 25[OH]D defi-
ciency in HIV-infected patients, as well as its role in pre-
dicting disease progression.
Methods
We performed a descriptive, cross-sectional study on a
group of 68 HIV-infected patients monitored in the
Regional HIV/AIDS Centre Mureş, during December
2012-February 2013. We determined plasma levels of
25[OH]D. We estimated the proportion of patients with
25[OH]D deficiency/insufficiency and correlated 25[OH]
D levels to HIV-RNA plasma viral load, CD4+ T-cells
count and associated pathology. Data were compared to
those obtained from a group of healthy, HIV-negative
volunteers. Statistical analysis was performed using the
GraphPad program.
Results
We studied 68 C-stage HIV-infected patients, 40 male:
28 female, with an average age of 26 and a median of 23.
The average plasma 25[OH]D level was 30.94 ng/mL,
median 30 ng/mL in HIV-positive patients compared to
an average of 44.72 ng/mL and median 39.82 ng/mL in
HIV-negative subjects (p=0.0109). 25[OH]D deficiency
<20 ng/mL was found in 23.52% HIV-infected patients,
while 26.47% HIV-positive subjects had medium levels of
25[OH]D insufficiency, between 20-30 ng/mL. Only
2 patients had severe 25[OH]D deficiency, below 10 ng/mL.
We did not find any statistically significant correlations of
25[OH]D levels with CD4+ T-cells level, HIV-RNA plasma
viral load or protease inhibitor therapy. Patients with HIV-
tuberculosis co-infection had significantly lower levels of
25[OH]D (p=0.0454) than HIV-positive subjects without
tuberculosis.
Conclusion
25[OH]D plasma levels are lower in HIV-infected
patients compared to the general population. Low 25[OH]
D levels are reported in patients with HIV-tuberculosis
co-infection. Low 25[OH]D levels may indicate unfavor-
able outcome in HIV-infected patients.
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